BlackRock Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-708,015
| Closed | -$248K | – | 4000 |
|
|
2016
Q3 | $248K | Buy |
708,015
+3,060
| +0.4% | +$1.07K | ﹤0.01% | 3193 |
|
|
2016
Q2 | $329K | Buy |
704,955
+45,237
| +7% | +$21.1K | ﹤0.01% | 3191 |
|
|
2016
Q1 | $897K | Buy |
659,718
+96,569
| +17% | +$131K | ﹤0.01% | 2557 |
|
|
2015
Q4 | $828K | Buy |
563,149
+2,568
| +0.5% | +$3.78K | ﹤0.01% | 2724 |
|
|
2015
Q3 | $886K | Sell |
560,581
-10,072
| -2% | -$15.9K | ﹤0.01% | 2676 |
|
|
2015
Q2 | $970K | Buy |
570,653
+139,017
| +32% | +$236K | ﹤0.01% | 2778 |
|
|
2015
Q1 | $600K | Buy |
431,636
+88,135
| +26% | +$123K | ﹤0.01% | 2853 |
|
|
2014
Q4 | $519K | Sell |
343,501
-2,108
| -0.6% | -$3.19K | ﹤0.01% | 2979 |
|
|
2014
Q3 | $712K | Buy |
345,609
+2,056
| +0.6% | +$4.24K | ﹤0.01% | 2747 |
|
|
2014
Q2 | $1.05M | Buy |
343,553
+19,114
| +6% | +$58.5K | ﹤0.01% | 2558 |
|
|
2014
Q1 | $811K | Buy |
324,439
+43,437
| +15% | +$109K | ﹤0.01% | 2643 |
|
|
2013
Q4 | $1.39M | Buy |
281,002
+3,174
| +1% | +$15.7K | ﹤0.01% | 2256 |
|
|
2013
Q3 | $633K | Buy |
277,828
+60,497
| +28% | +$138K | ﹤0.01% | 2755 |
|
|
2013
Q2 | $482K | Buy |
+217,331
| New | +$482K | ﹤0.01% | 2868 |
|